Arch Capital Group Ltd. (NASDAQ:ACGL – Get Free Report) Director Brian Posner sold 3,000 shares of Arch Capital Group stock in a transaction dated Wednesday, June 3rd. The shares were sold at an average price of $19.66, for a total value of $58,980.00. The transaction was disclosed in a document filed with the Securities & […]

Enphase Energy, Inc. (NASDAQ:ENPH – Get Free Report) Director Richard Mora sold 700 shares of the company’s stock in a transaction that occurred on Monday, June 1st. The stock was sold at an average price of $64.20, for a total value of $44,940.00. Following the completion of the transaction, the director owned 13,922 shares of […]

MongoDB, Inc. (NASDAQ:MDB – Get Free Report) Director Roelof Botha sold 44,050 shares of the business’s stock in a transaction dated Tuesday, June 2nd. The stock was sold at an average price of $398.07, for a total transaction of $17,534,983.50. Following the sale, the director directly owned 150,550 shares of the company’s stock, valued at […]

Alphabet Inc. (NASDAQ:GOOG – Get Free Report) Director Frances Arnold sold 102 shares of Alphabet stock in a transaction that occurred on Friday, May 29th. The stock was sold at an average price of $381.00, for a total transaction of $38,862.00. Following the completion of the transaction, the director directly owned 18,721 shares in the […]

Cytokinetics, Incorporated (NASDAQ:CYTK – Get Free Report) Director B Lynne Parshall sold 5,000 shares of the firm’s stock in a transaction dated Monday, June 1st. The shares were sold at an average price of $74.08, for a total value of $370,400.00. Following the sale, the director owned 15,784 shares in the company, valued at $1,169,278.72. […]

Strategy Inc (NASDAQ:MSTR – Get Free Report) Director Jarrod Patten sold 7,250 shares of the business’s stock in a transaction dated Thursday, May 28th. The stock was sold at an average price of $147.74, for a total value of $1,071,115.00. Following the transaction, the director owned 28,000 shares in the company, valued at approximately $4,136,720. […]

Rocket Lab Corporation (NASDAQ:RKLB – Get Free Report) Director Alexander Slusky sold 60,000 shares of Rocket Lab stock in a transaction dated Thursday, May 28th. The shares were sold at an average price of $149.40, for a total value of $8,964,000.00. Following the transaction, the director directly owned 374,675 shares in the company, valued at […]

Immunovant, Inc. (NASDAQ:IMVT – Get Free Report) Director Andrew Fromkin sold 221,951 shares of the firm’s stock in a transaction on Thursday, May 28th. The shares were sold at an average price of $33.51, for a total value of $7,437,578.01. Following the completion of the sale, the director directly owned 74,382 shares of the company’s […]